Millennium Management’s Celgene Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-127,224
Closed -$132K – 4038
2016
Q3
$132K Hold
127,224
– – ﹤0.01% 3081
2016
Q2
$186K Hold
127,224
– – ﹤0.01% 2917
2016
Q1
$167K Hold
127,224
– – ﹤0.01% 3001
2015
Q4
$153K Sell
127,224
-43,366
-25% -$57.7K ﹤0.01% 3175
2015
Q3
$275K Sell
170,590
-84,660
-33% -$163K ﹤0.01% 2960
2015
Q2
$531K Sell
255,250
-62,141
-20% -$159K ﹤0.01% 2613
2015
Q1
$943K Sell
317,391
-5,000
-2% -$15.8K ﹤0.01% 2346
2014
Q4
$1.02M Sell
322,391
-18,627
-5% -$62.8K ﹤0.01% 2480
2014
Q3
$1.16M Hold
341,018
– – ﹤0.01% 2209
2014
Q2
$887K Sell
341,018
-32,300
-9% -$89.4K ﹤0.01% 2266
2014
Q1
$1.05M Sell
373,318
-66,828
-15% -$202K ﹤0.01% 2193
2013
Q4
$1.2M Sell
440,146
-354,932
-45% -$996K ﹤0.01% 2155
2013
Q3
$6.39M Buy
795,078
+316,720
+66% +$2.44M 0.02% 971
2013
Q2
$3.5M Buy
+478,358
New +$3.47M 0.01% 1243

Other funds holding CELGZ

Millennium Management's CELGZ Position: Q4 2016 in Review

Millennium Management sold out of Celgene Contingent Value Rights (CELGZ) in Q4 2016, closing a stake of 127,224 shares — an estimated $132K sold.

Millennium Management first reported a position in CELGZ in Q2 2013 and held it in 14 quarters. The position peaked at $6.39M in Q3 2013. 26 funds tracked by Wall St. Rank hold CELGZ as of Q4 2016.

  • Millennium Management reported no remaining Celgene Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
  • Millennium Management sold 127,224 Celgene Contingent Value Rights shares in Q4 2016, an estimated $132K.
  • Millennium Management first reported a position in Celgene Contingent Value Rights in Q2 2013 and held it in 14 quarters.
  • Millennium Management's Celgene Contingent Value Rights position peaked at $6.39M in Q3 2013.
  • 26 funds tracked by Wall St. Rank held Celgene Contingent Value Rights as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.